Status:
TERMINATED
Ziprasidone and Sertraline in PTSD
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Post-traumatic Stress Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Serotonin re-uptake inhibitors, such as sertraline, are the medication of choice in post-traumatic stress disorder. However, it takes several weeks before they ameliorate symptoms. Therefore, we will ...
Detailed Description
A current problem in the pharmacotherapy of PTSD is that the medication of choice, serotonin re-uptake inhibitors, take several weeks before they show considerable effects on PTSD symptoms. Addition o...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Post-Traumatic Stress Disorder
Exclusion
- Lifetime psychotic disorders, current substance dependency, gravidity, lactation, tartrazine hypersensitivity, contraindication against sertraline or ziprasidone
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00248261
Start Date
November 1 2005
End Date
June 1 2010
Last Update
February 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UKE, Dept. of Psychiatry and Psychotherapy
Hamburg, Germany, 2ß246